Is Nevolat the Same as Mounjaro? What the Name Confusion Is Really About

Nevolat is not a licensed medicine name in the UK, Mounjaro (tirzepatide) is the authorised brand for weight management.
Tirzepatide works on two gut-hormone receptors (GIP and GLP-1), making it the only dual-agonist weight-loss medicine currently licensed in the UK.
Names like Nevolat sometimes circulate in connection with unlicensed, compounded or counterfeit products, the MHRA has warned about fake weight-loss pens sold online.
Mounjaro is a prescription-only medicine; clinical assessment by a GPhC-registered prescriber is a legal requirement before it can be supplied.

Nevolat is not a recognised medicine name in the UK. If you've come across it online or heard it used alongside Mounjaro, it almost certainly refers to tirzepatide — the active ingredient in Mounjaro — but under an unofficial, unverified or simply mistaken label. Mounjaro is the only UK-licensed brand name for tirzepatide used in weight management. It's a prescription-only medicine, which means a prescriber must assess your suitability before it can be dispensed, no route around that exists through a legitimate pharmacy.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to tell whether a product name you've seen is the real thing, and what Mounjaro actually is

You've seen the name Nevolat and wondered if it's just another word for Mounjaro

This is a question our prescribers hear most weeks, usually from people who've spotted a name in a forum thread or been approached by a seller on social media. Sometimes these names are honest mix-ups, a brand name used abroad, a compounded product, or simply a misspelling that got copied and shared. Other times they're attached to products that have no legitimate place in a licensed UK supply chain at all.

The situation with Nevolat fits the first category: it does not correspond to any MHRA-authorised product for weight management in the UK. Mounjaro, made by Eli Lilly, is the licensed brand. Its active ingredient is tirzepatide, and if you want to explore whether tirzepatide is the same as Mounjaro and how the two names relate, that page covers the distinction clearly. The short version: it activates both the GIP and GLP-1 gut-hormone receptors, and if you've ever wondered whether GLP-1 is the same as Mounjaro and what that receptor connection actually means, that page explains it clearly. This dual action slows gastric emptying and reduces appetite, a dual action that no other licensed weight-loss medicine currently shares.

Seeing an unfamiliar name attached to something described as a weight-loss injection should prompt one practical question: is this product on the MHRA's approved list, and is the pharmacy selling it registered with the GPhC? If the answer to either is unclear, the safest move is to step away. The NHS page on tirzepatide gives a clear account of what the authorised medicine looks like and what it is licensed for.

Why unlicensed names matter more than they might seem

It can feel like a minor detail, a name is just a name. But when a product circulates under an unofficial label, there's no way to verify what it actually contains. The MHRA has seized large quantities of fake weight-loss pens sold through social media and unregistered websites, some of which contained insulin rather than the expected active ingredient. The consequences for people who injected those products were serious. You can report any suspect seller directly at the MHRA Yellow Card scheme, which handles both side-effect reports and intelligence about potentially unsafe products.

Licensed Mounjaro comes in a specific pre-filled KwikPen format, in verified strengths from 2.5mg up to 15mg, sourced through Eli Lilly's authorised UK distribution network. Each pen carries the black triangle (▼) symbol indicating it is subject to additional MHRA monitoring, an extra layer of post-market surveillance that counterfeit or unlicensed products simply don't carry. If the product you've seen doesn't look like that, or if the seller cannot point you to a GPhC-registered pharmacy, that gap matters.

There's a separate but related question worth flagging here: sometimes people ask whether Mounjaro and Wegovy are the same thing, or whether Ozempic covers the same ground. They don't, they use different active ingredients and carry different UK licences. The Mounjaro comparisons page unpacks those distinctions clearly if you need them.

What Mounjaro is actually licensed to do, and what a real prescription route looks like

In the UK, Mounjaro holds a licence for weight management in adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related health condition such as high blood pressure, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds may apply for some ethnic backgrounds under NICE guidance. The Mounjaro treatment page sets out the eligibility criteria in full.

Because it's a prescription-only medicine, the supply route has a fixed shape: a clinical assessment, a prescriber who decides whether it's appropriate for you specifically, a valid prescription, and a pharmacy that can be verified on the GPhC register. At nume, a GPhC-registered Independent Prescriber personally reviews every consultation, not an automated system, not a questionnaire that approves everyone. If you've been wondering about the cost side of private treatment, there's a straightforward breakdown on the Mounjaro cost page that covers what private pricing typically includes.

If a product called Nevolat or any other unfamiliar name is being offered to you, that route falls outside the licensed supply chain. The safest step is always a legitimate consultation with a registered prescriber who can confirm the right medicine, the right dose, and whether it suits your health picture. That conversation is free at nume, and it's where the process properly begins. If you have broader questions about how GLP-1 medicines work, including less obvious effects such as tirzepatide jaw clenching, which some people notice during treatment, our FAQs are a good starting point.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions